| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | ISO 9001 |
| Suitable for: | Elderly |
| State: | Solid |
| Purity: | >99% |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Prodcut name | Semaglutide |
| Standard packing material | Aluminum foil bag inside, then waterproof bag or carton |
| Appearance | White powder |
| Purity | 99% |
| Storage |
Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccatedbelow -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. |
GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide. Semaglutide is also known Ozempc or Wegvy. Tirzepatide is known as Mounjao.
Tirzepatide is dosed at 5-15mg per week
Semaglutide is dosed at 0.5-2.4mg per week
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.
Weekly semaglutide 2.4 mg (Wegoy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²
Semaglutide 1 mg injection (Ozempc) was first approved as a treatment for type 2 diabetes in 2017.
Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placebo| WEIGHT LOSS | |||||
| 1 | Semaglutide( Ozempc ) | 910463-68-2 | 2 | Tirzepatide(LY3298176) | 2023788-19-2 |
| 3 | 5-Amino 1MQ | 42464-96-0 | 4 | Liraglutide | 204656-20-2 |
| 5 | 7-Keto | 566-19-8 | 6 | Cetilistat | 282526-98-1 |
| 7 | Synephrine | 5985-28-4 | 8 | Rimonabant | 168273-06-1 |
| 9 | Bupropion | 34911-55-2 | 10 | L-Carnitine | 541-15-1 |
| Appearance | White powder. |
| Purity | 99%min |
| Single Impurity (HPLC) | 1.0%max |
| Amino Acid Composition | ±10% of theoretical |
| Peptide Content (N%) | ≥80.0% |
| Water Content(Karl Fischer) | ≤6.0% |
| Acetate Content (HPIC) | ≤15.0% |
| MS(ESI) | Consistent |
| Mass Balance | 95.0~105.0% |
| Specific Rotation (20/D) | -65.0~-75.0°(c=0.5 1%HAc) |
| Solubility | H 2 O:40 mg / mL |
| Storage condition | -20ºC |
| Shelf life | 2 years |
1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment:
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}